-
Although reducing student loan debt has been a focus for President Joe Biden, the poll found that Americans are more likely to say medical debt relief should be a government priority.
-
While some doctors seem eager for a huge payoff, others are warily watching what happens when private equity firms take charge of orthopedic practices.
-
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?
-
Her sleuthing took over a year but knocked thousands of dollars off the hospital’s charges — and provides a playbook for other consumers.
-
New policies to keep medical bills from sinking credit ratings sound good but will likely fall short for many hit hardest by debt — especially Black Americans in the South, such as Penelope Wingard.
-
West Virginia Sen. Joe Manchin reached an agreement with Senate Majority Leader Chuck Schumer that had eluded them for months on health care costs, energy and climate issues.
-
A dump of tens of thousands of colossal digital files from a single insurer is not unusual, and it'll be weeks before data firms can put the information in a usable format for employers and patients.
-
New government rules are forcing insurers to post on websites what they pay for care or be fined, allowing consumers and employers to comparison shop for health services or negotiate better rates.
-
A local chapter of the Alliance for Retired Americans wants Sens. Rick Scott and Marco Rubio to support legislation that would decrease health care and prescription drug costs for seniors.
-
MRIs done early for uncomplicated low back pain and routine vitamin D tests "just to be thorough" are considered "low-value care" and can lead to further testing that can cost patients thousands.